Last updated on November 2017

A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)


Brief description of study

A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)

Detailed Study Description

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).

Clinical Study Identifier: TX15268

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

West Michigan Clinical Research Center

West Michigan Clinical Research Center
Wyoming, MI USA
  Connect »